Ablation Devices Market 2021 - 2027 Global Industry Size, Share, Growth, Trends, COVID-19 Impact Analysis, Top Key Players Outlook | Medtronic plc, Conmed Corporation, Olympus Corporation, Johnson & Johnson, Smith & Nephew plc

The global ablation devices market size was $3,047 million in 2015 and is estimated to reach $6,658 million by 2027, growing a CAGR of 11.7% from 2016 to 2027.

Ophthalmology segment would be the most lucrative segment for investment in the ablation devices market for the new as well as existing players. This is because there are numerous players, products, and patents already available in the market for cancer and cardiology ablation devices, making the competitive rivalry intense. However, ophthalmology segment has untapped areas that could provide great opportunities for new entrants as well as existing players.

Download Sample Report with Detailed COVID-19 Impact Analysis at:

https://www.alliedmarketresearch.com/request-sample/1749

Thermal segment dominated the world ablation devices market in 2015 and is expected to continue with its dominance throughout the forecast period. This is attributed to the various applications of thermal ablation devices for cancer and cardiovascular surgeries. However, owing to the higher success rate and advantages, non-thermal technologies is estimated to be the fastest growing segment propelling at an estimated CAGR of 17.7%.

In the year 2015, cancer segment held the majority of the market share due to increase in the number of cancer patients and high precision of ablation techniques to destroy cancer cells. In addition, it is estimated to retain its market position throughout the forecast period, registering a CAGR of 11.4%. Cardiovascular is anticipated to be the fastest growing segment, as cardiac ablation provides site-specific treatment and prevents infection to the surrounding tissues.

Key findings of the Ablation Devices Market:

Varicose veins segment is estimated to exhibit a CAGR of 15.6%, among procedure types.

Cardiovascular is anticipated to be the fastest growing segment throughout the analysis period.

Epidermal and subcutaneous cryoablation devices are the fastest growing sub-markets from cryoablation devices segment.

Turkey ablation devices market is projected to grow at a CAGR of 10.8%.

Automated/robotic ablation devices market is projected to grow at a CAGR of 14.3%.

For Purchase Enquiry at:

https://www.alliedmarketresearch.com/purchase-enquiry/1749

This can be attributed to the innovation in technologically advanced ablation devices. Moreover, common occurrence of chronic diseases, such as cancer and atrial fibrillation, and the rise in awareness about the benefits of ablation techniques are anticipated to contribute towards the market growth.

Presently, North America and Europe have the highest growth potential due to established reimbursement policies, high buying power, rapid adoption of minimal-invasive therapies, rise in the count of aging population, and increasing prevalence of patients with chronic illnesses. However, the market would gain traction in the developing regions of Asia-Pacific and Latin America as well, due to the increase in urbanization & disposable income, large number of undiagnosed patients, and growing awareness about ablation devices.

The key players profiled in this report include Boston Scientific Corporation, AngioDynamics, Inc., AtriCure, Inc., St. Jude Medical, Inc., Medtronic plc, Conmed Corporation, Olympus Corporation, Johnson & Johnson, Smith & Nephew plc, and BTG plc.

To View the complete report, visit the website at:

https://www.alliedmarketresearch.com/ablation-devices-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

AMR launched its user-based online library of reports and company profiles, Avenue. An e-access library is accessible from any device, anywhere, and at any time for entrepreneurs, stakeholders, and researchers and students at universities. With reports on more than 60,000 niche markets with data comprising of 600,000 pages along with company profiles on more than 12,000 firms, Avenue offers access to the entire repository of information through subscriptions. A hassle-free solution to clients’ requirements is complemented with analyst support and customization requests.

This release was published on openPR.